|
1
|
Souadka A, Habbat H, Majbar MA, Benkabbou A, Amrani L, Ghannam A, El Ahmadi B, Belkhadir ZH, Mohsine R. Cancer patients should be considered as a high risk priority target in the coronavirus disease 2019 vaccination process. J Surg Oncol 2021; 124:453-454. [PMID: 33878206 PMCID: PMC8251233 DOI: 10.1002/jso.26508] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2021] [Accepted: 03/14/2021] [Indexed: 11/11/2022]
Affiliation(s)
- Amine Souadka
- Surgical Oncology Department, National Institute of Oncology, University Mohammed V, Rabat, Morocco
| | - Hajar Habbat
- Surgical Oncology Department, National Institute of Oncology, University Mohammed V, Rabat, Morocco
| | - Mohammed Anass Majbar
- Surgical Oncology Department, National Institute of Oncology, University Mohammed V, Rabat, Morocco
| | - Amine Benkabbou
- Surgical Oncology Department, National Institute of Oncology, University Mohammed V, Rabat, Morocco
| | - Laila Amrani
- Surgical Oncology Department, National Institute of Oncology, University Mohammed V, Rabat, Morocco
| | - Abdelilah Ghannam
- Intensive Care Department, National Institute of Oncology, University Mohammed V, Rabat, Morocco
| | - Brahim El Ahmadi
- Intensive Care Department, National Institute of Oncology, University Mohammed V, Rabat, Morocco
| | | | - Raouf Mohsine
- Surgical Oncology Department, National Institute of Oncology, University Mohammed V, Rabat, Morocco
| |
Collapse
|
|
2
|
Coomes EA, Al‐Shamsi HO, Meyers BM, Alhazzani W, Alhuraiji A, Chemaly RF, Almuhanna M, Wolff RA, Ibrahim NK, Chua ML, Hotte SJ, Elfiki T, Curigliano G, Eng C, Grothey A, Xie C. Evolution of Cancer Care in Response to the COVID-19 Pandemic. Oncologist 2020; 25:e1426-e1427. [PMID: 32536024 PMCID: PMC7323244 DOI: 10.1634/theoncologist.2020-0451] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2020] [Accepted: 05/21/2020] [Indexed: 12/22/2022] Open
Affiliation(s)
- Eric A. Coomes
- Division of Infectious Disease, Department of Medicine, University of TorontoTorontoCanada
| | - Humaid O. Al‐Shamsi
- Medical Oncology Department, Alzahra Hospital Dubai, Dubai, United Arab Emirates; Department of Medicine, University of Sharjah, Sharjah, United Arab Emirates; Emirates Oncology SocietyDubaiUnited Arab Emirates
| | - Brandon M. Meyers
- Department of Oncology, Juravinski Cancer Centre, McMaster UniversityHamiltonCanada
| | - Waleed Alhazzani
- Department of Health Research Methods, Evidence, and Impact and Department of Medicine, McMaster UniversityHamiltonCanada
| | - Ahmad Alhuraiji
- Department of Hematology, Kuwait Cancer Control CenterKuwait CityKuwait
| | - Roy F. Chemaly
- Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer CenterHoustonTexasUSA
| | | | - Robert A. Wolff
- Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer CenterHoustonTexasUSA
| | - Nuhad K. Ibrahim
- Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer CenterHoustonTexasUSA
| | - Melvin L.K. Chua
- Divisions of Radiation Oncology and Medical Sciences, National Cancer Center Singapore, Singapore; Oncology Academic Program, Duke–National University of Singapore Medical School, Singapore; Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan UniversityWuhanPeople's Republic of China
| | - Sebastien J. Hotte
- Department of Oncology, Juravinski Cancer Centre, McMaster UniversityHamiltonCanada
| | - Tarek Elfiki
- Windsor Regional Cancer Center, Windsor, Canada; Department of Oncology, Schulich School of Medicine, University of Western OntarioLondonCanada
| | - Giuseppe Curigliano
- Department of Oncology and Hemato‐Oncology and Division of Early Drug Development for Innovative Therapy, University of Milan, Milan, Italy; European Institute of Oncology, IRCCS, and University of MilanoMilanItaly
| | - Cathy Eng
- Vanderbilt‐Ingram Cancer CenterNashvilleTennesseeUSA
| | - Axel Grothey
- West Cancer Center, University of TennesseeMemphisTennesseeUSA
| | - Conghua Xie
- Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan UniversityWuhanPeople's Republic of China
| |
Collapse
|